Considering that the neurobiology of substance use disorders is highly heterogeneous, it is unlikely that a single pharmacological target could effectively address the range of SUDs, as claimed, Bisaga said
The FDA recently approved oral Wegovy (25mg semaglutide) as the first oral GLP-1 pill specifically approved for weight loss, launching in early 2026
Counsel outlined the procedural posture of those cases, any upcoming trial settings or dispositive motions, and coordination issues between the MDL and parallel state proceedings
Supplements support habits
Provides a profound, ongoing reduction in subconscious snacking urges and compulsive sugar cravings, allowing you to establish and sustain structured, healthy nutritional habits naturally
B.LindstrmE